Table 3

EOGBS rates in the prescreening, screening and postscreening periods

Time periodEOGBS n/NEOGBS/1000 cases (95% CI)
Prescreening (2009–2013)25/25 2760.99 (0.64 to 1.46)
Screening (2014–2015)3/90980.33 (0.07 to 0.96)
Postscreening (2016–2017)9/50331.79 (0.82 to 3.39)
  • EOGBS, early-onset group B Streptococcus.